Skip to main content
Equibles

TRIB · Trinity Biotech PLC

Track TRIB — free

Use TRIB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research TRIB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$5.78 +0.09 (+1.58%)
Rebalance outlook locked
Market Cap
$5.50M
Shares
813,132
Volume · Oct 5 3112 Avg daily vol (50 sessions) 24.04K

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$5.69 Open$5.70 Day$5.05–5.83 52W close$0.34–13.38 Avg vol 30d14K Short int8K · 1.0% float · 1.0d Short vol8% Last earningsSep 30, 2024 DataJan 2020–Oct 2026

Up next

Q3 2024 earnings call transcript
call held Sep 30, 2024

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
—
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
—
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
1.0%
Latest settlement · 1.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Neutral Momentum Strong Sentiment Neutral Fundamentals Limited Quant / Vol Very High
Market backdrop VIX 15.3 · calm Equity put/call 0.58
Technical
price trend
Neutral
50 / 200-day cross No cross
Price vs 200-day avg +95%
above
Price vs 50-day avg −40%
below
RSI (14) 24
oversold
MACD trend Negative
52-week position 41%
mid-range
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Strong
1-month return −41%
trailing
6-month return +701%
trailing
YTD return +620%
this year
Relative strength +689%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $10 › 200d $3 — 50d above 200d
Institutional flow Distributing
-20% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.98% of float · ▼ -18.8% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
20 holders — near 3-yr low, contrarian setup
Squeeze score 31
low risk · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very High
Volatility 2408%
annualized · 1-yr
Max drawdown −73%
past year
ATR 14.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Latest guidance · from the Earnings Call filed Jun 30, 2020
Revenue guidance · September quarter $28M

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Neutral
2 · 4 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+95% Bullish
Price vs 50-day avg
−40% Bearish
RSI (14)
24 Neutral
MACD trend
Negative Bearish
52-week position
41% Neutral
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $10 › 200d $3 — 50d above 200d
Institutional flow Distributing
-20% holders QoQ · +1 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
0.98% of float · ▼ -18.8% MoM · 1.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
20 holders — near 3-yr low, contrarian setup
Price context
position in its 52-week range
Range low $0 Now $6 · 41% Range high $13
vs 200-day avg +95% vs 50-day avg -40%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Medical Devices — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
TRIB
Trinity Biotech PLC
this stock
$5.50M — — — 1.0%
ABT
Abbott Laboratories
 $174.90B -22.2% +5.7% 28.1 1.1%
MDT
Medtronic plc
 $113.38B -10.1% +8.4% 21.8 1.3%
SYK
Stryker Corp
 $104.47B -21.6% +11.2% 28.2 2.0%
BSX
Boston Scientific Corp
 $63.59B -55.3% +12.5% 17.8 3.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Reducing
Holders
20
% held
4.3%
Net QoQ
-2.0K sh
Top holder
HUNTER ASSOCIATES INVESTM…
Held Float
View
Held by Funds
Fund positions
1
View
Short & Settlement
Short Interest Falling
Shares short
8.0K
Days to cover
1.0d
Change
-1.9K sh
View
Short Volume
Short vol %
8%
As of
Oct 5, 2026
Short Total
View
Fails to Deliver
FTD shares
924
Value
$8.8K
As of
Sep 4, 2026
View
Off-Exchange
Off-exchange %
37.5%
Week of
Aug 31, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
6-K
Filed
Oct 5, 2026
This year
25
View
Earnings & Events
Webcasts
Last webcast
Sep 30, 2024
View

Performance

5D 20D 120D MTD YTD
TRIB -15.8% -40.7% +701.4% -11.5% +620.3%
SPY -0.2% -0.5% +12.2% +0.9% +12.9%
vs SPY -15.6% -40.3% +689.2% -12.4% +607.4%
Key facts CIK 888721 CUSIP 896438603 Visit website Investor relations